These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 460633)

  • 1. [Pharmacokinetics of a new aminoglycoside: kanendomycin].
    Di Nola F; Eandi M; Soranzo ML; Bosio G; Sachelariu N; Salassa B; Bramato C
    Minerva Med; 1979 May; 70(25):1803-12. PubMed ID: 460633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The antibacterial activity of amikacin in comparison with four other aminoglycoside antibiotics (proceedings)].
    Schassan HH
    Zentralbl Bakteriol Orig A; 1976 Aug; 235(1-3):320-8. PubMed ID: 983520
    [No Abstract]   [Full Text] [Related]  

  • 3. [Some data from studying and using aminoglycoside antibiotics in reconstructive surgery].
    Vasina TA; Ved'mina EA; Ismagulova GD
    Antibiotiki; 1975 Oct; 20(10):941-5. PubMed ID: 813564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The plasma level of kanamycin after intravenous and intramuscular injections in horses].
    Klee S; Nürnberger MC; Keller H; Ungemach FR
    Tierarztl Prax; 1996 Aug; 24(4):368-72. PubMed ID: 9012022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmacokinetics of some aminoglycoside antibiotics in the horse.
    Baggot JD; Love DN; Rose RJ; Raus J
    J Vet Pharmacol Ther; 1981 Dec; 4(4):277-84. PubMed ID: 7349342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The susceptibility of recently isolates of gram-negative bacteria to amikacin and other aminoglycosides.
    Lexomboon U; Duangmani C; Srimunta C
    J Med Assoc Thai; 1979 Oct; 62(10):544-9. PubMed ID: 501262
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical pharmacokinetics of amikacin in dogs.
    Baggot JD; Ling GV; Chatfield RC
    Am J Vet Res; 1985 Aug; 46(8):1793-6. PubMed ID: 4037511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sensitivity to kanendomycin in vitro of gram-negative bacterial strains].
    Carbone M; Focà A; Merendino R; De Rosa M
    G Ital Chemioter; 1977; 24(1-2):103-8. PubMed ID: 615751
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pharmacokinetics of arbekacin in dogs. I. Serum concentration and urinary excretion].
    Tomono N; Sannomiya F; Nakayoshi T; Shinkai S; Fujita M
    Jpn J Antibiot; 1987 Feb; 40(2):365-75. PubMed ID: 3599385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and bioavailability of piretanide in healthy volunteers following intramuscular administration.
    Trenk D; Wagner F; Jähnchen E; Spahn H; Mutschler E
    Arzneimittelforschung; 1987 Dec; 37(12):1382-5. PubMed ID: 3449067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and bioavailability of cefquinome in healthy piglets.
    Li XB; Wu WX; Su D; Wang ZJ; Jiang HY; Shen JZ
    J Vet Pharmacol Ther; 2008 Dec; 31(6):523-7. PubMed ID: 19000274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In vitro antibacterial activity of dibekacin on staphylococci, streptococci and aerobic Gram negative bacilli].
    Deforges L; Van Thoi J; Le Soussy CJ; Duval J
    Nouv Presse Med; 1982 Nov; 11(46):3385-90. PubMed ID: 7155845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Microbiological characteristics of kanendomycin].
    Blandino G; Mattina R; Speciale A; Toscano MA
    G Ital Chemioter; 1977; 24(1-2):7-10. PubMed ID: 615765
    [No Abstract]   [Full Text] [Related]  

  • 14. Aminoglycoside antibiotics. Selected aspects of antibacterial activity and pharmacology.
    Rosenthal SL
    N Y State J Med; 1975 Mar; 75(4):535-47. PubMed ID: 1056513
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pharmacokinetics of arbekacin in dogs. II. The distribution of arbekacin in tissues].
    Tomono N; Nakayoshi T; Shinkai S; Fujita M
    Jpn J Antibiot; 1987 Feb; 40(2):377-84. PubMed ID: 3599386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The pharmacokinetic studies on astromicin in dogs. Intramuscular, intravenous or drip intravenous administration].
    Kobayashi S; Inoue A; Deguchi T
    Jpn J Antibiot; 1986 Jun; 39(6):1443-52. PubMed ID: 3761558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of cefepime and comparison with those of ceftiofur in horses.
    Guglick MA; MacAllister CG; Clarke CR; Pollet R; Hague C; Clarke JM
    Am J Vet Res; 1998 Apr; 59(4):458-63. PubMed ID: 9563631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and absolute bioavailability of intramuscular tranexamic acid in man.
    Puigdellívol E; Carral ME; Moreno J; Plà-Delfina JM; Jané F
    Int J Clin Pharmacol Ther Toxicol; 1985 Jun; 23(6):298-301. PubMed ID: 4018929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study of the microbiological activity in vitro of BB-K-8, a new aminoglycoside antibiotic].
    Ravagnan G; Rasura M; Piccolomini R
    Boll Soc Ital Biol Sper; 1976 Sep; 52(18):1440-6. PubMed ID: 1024552
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacokinetics of tiapride and absolute bioavailability of three extravascular forms.
    Rey E; d'Athis P; Richard MO; de Lauture D; Olive G
    Int J Clin Pharmacol Ther Toxicol; 1982 Feb; 20(2):62-7. PubMed ID: 7061180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.